US50535E1082 - Common Stock
PROSOMNUS INC
NASDAQ:OSA (4/17/2024, 8:17:27 PM)
After market: 0.44 -0.03 (-6.38%)0.47
-0.05 (-10.29%)
Prosomnus, Inc. is a medical technology company, which engages in the business of developing, manufacturing, and marketing precision intraoral medical devices. The company is headquartered in Pleasanton, California and currently employs 129 full-time employees. The company went IPO on 2021-06-15. The Company’s intraoral medical devices are engineered to track the treatment plan and anatomy of each patient. Its precision intraoral devices are Food and Drug Administration (FDA)-cleared, patented and covered by commercial medical insurance, Medicare, TRICARE and other Government-sponsored healthcare plans around the world, representing approximately 200 million covered lives. The Company’s products include ProSomnus EVO Sleep and Snore Device, ProSomnus EVO SELECT Sleep and Snore Device, ProSomnus EVO [PH] Sleep and Snore Device, ProSomnus [CA] LP Sleep and Snore Device and ProSomnus [MOG] Morning Occlusal Guide. The Company’s wholly owned subsidiaries include ProSomnus Holdings, Inc. and ProSomnus Sleep Technologies, Inc.
PROSOMNUS INC
5675 Gibraltar Dr
Pleasanton CALIFORNIA
P: 18445375337
Employees: 129
Website: https://prosomnus.com/
OSA stock results show that ProSomnus missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ProSomnus (NASDAQ:OSA) just reported results for the fourth quarter of 2023.Pro...
ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results...
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call ...
Here you can normally see the latest stock twits on OSA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: